Insider Transactions in Q3 2023 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q3 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 15
2023
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Grant, award, or other acquisition
|
Direct |
28,354
+14.02%
|
-
|
Sep 15
2023
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
86,076
+40.8%
|
-
|
Sep 15
2023
|
Marie L. Jones VP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
7,595
+12.02%
|
-
|
Sep 15
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
222,785
+22.62%
|
-
|
Sep 15
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121,519
+34.47%
|
-
|
Aug 17
2023
|
Kevin M Klemz EVP/Chief Legal Officer/Sec. |
SELL
Open market or private sale
|
Direct |
1,539
-3.82%
|
$30,780
$20.11 P/Share
|
Aug 03
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,587
-5.67%
|
$144,914
$22.13 P/Share
|
Jul 28
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,643
+2.19%
|
$96,430
$10.8 P/Share
|
Jul 20
2023
|
Marie L. Jones VP, Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+4.0%
|
$12,000
$6.11 P/Share
|
Jul 11
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.37%
|
$31,000
$31.56 P/Share
|
Jul 11
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.37%
|
$1,000
$1.6 P/Share
|
Jul 06
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
69
-0.06%
|
$2,070
$30.79 P/Share
|